Floatz logo

Interleukin-1

Testicular Neoplasms

National Cancer Institute (NCI)Phase 1Dormant
CC
47/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
32/ 100
Competitive Position
95/ 100

Competitive context

1 Active assets in the Testicular Neoplasms cohort.

Asset / SponsorPhaseRating
Pembrolizumab
Nasser Hanna, M.D.
Phase 2CCC
Sgn-Alpv
Seagen Inc.
Phase 1CC

Same molecule, other indications

Interleukin-1 is also rated in:

metastatic neoplasmDormant
CC
Indicative ·
42 / 100
View asset →
breast neoplasmDormant
CC
Indicative ·
40 / 100
View asset →
lymphomaDormant
CC
Indicative ·
40 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →